VIAPIANA, Ombretta
 Distribuzione geografica
Continente #
EU - Europa 14.180
NA - Nord America 13.969
AS - Asia 9.901
SA - Sud America 1.319
AF - Africa 311
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 11
Totale 39.714
Nazione #
US - Stati Uniti d'America 13.676
RU - Federazione Russa 5.144
SG - Singapore 3.910
GB - Regno Unito 3.020
CN - Cina 2.897
IT - Italia 2.004
BR - Brasile 1.031
DE - Germania 912
VN - Vietnam 866
HK - Hong Kong 808
SE - Svezia 717
FR - Francia 677
IE - Irlanda 604
FI - Finlandia 422
KR - Corea 288
BD - Bangladesh 274
IN - India 209
CA - Canada 158
JP - Giappone 156
UA - Ucraina 156
TR - Turchia 131
AR - Argentina 108
PL - Polonia 93
NL - Olanda 90
MX - Messico 86
NG - Nigeria 75
ES - Italia 71
ID - Indonesia 66
ZA - Sudafrica 65
IQ - Iraq 57
AT - Austria 54
BE - Belgio 49
EC - Ecuador 45
BJ - Benin 36
VE - Venezuela 35
UZ - Uzbekistan 31
CO - Colombia 30
PK - Pakistan 30
CL - Cile 26
RO - Romania 24
EG - Egitto 21
MA - Marocco 21
TG - Togo 21
IR - Iran 19
LT - Lituania 19
SA - Arabia Saudita 19
CH - Svizzera 18
KE - Kenya 18
PE - Perù 18
AU - Australia 17
AE - Emirati Arabi Uniti 14
IL - Israele 14
AZ - Azerbaigian 12
MY - Malesia 12
PH - Filippine 12
CR - Costa Rica 11
PY - Paraguay 11
CZ - Repubblica Ceca 10
DZ - Algeria 10
AL - Albania 9
GR - Grecia 9
HR - Croazia 9
JM - Giamaica 9
NP - Nepal 9
BG - Bulgaria 8
DK - Danimarca 8
JO - Giordania 8
TN - Tunisia 8
BO - Bolivia 7
ET - Etiopia 7
LB - Libano 7
PT - Portogallo 7
SN - Senegal 7
HU - Ungheria 6
QA - Qatar 6
UY - Uruguay 6
AM - Armenia 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
SV - El Salvador 5
TH - Thailandia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CI - Costa d'Avorio 4
EE - Estonia 4
EU - Europa 4
GE - Georgia 4
HN - Honduras 4
LV - Lettonia 4
NO - Norvegia 4
RS - Serbia 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
KW - Kuwait 3
KZ - Kazakistan 3
MK - Macedonia 3
PS - Palestinian Territory 3
SI - Slovenia 3
Totale 39.656
Città #
Southend 2.632
Singapore 2.086
Moscow 1.754
Ashburn 1.666
San Jose 1.391
Chandler 1.335
Dallas 1.249
Jacksonville 883
Hong Kong 795
Dublin 600
Verona 489
Beijing 486
Ann Arbor 475
Woodbridge 465
The Dalles 385
Council Bluffs 356
New York 338
Houston 306
Los Angeles 294
Ho Chi Minh City 270
Lawrence 234
Princeton 234
Wilmington 233
Jinan 224
Redmond 194
Bologna 192
Hanoi 184
Nanjing 173
Shenyang 173
Munich 143
Tokyo 138
Helsinki 136
Buffalo 132
Milan 124
Hebei 104
São Paulo 104
Tianjin 104
Redondo Beach 102
Santa Clara 101
Sindelfingen 85
Warsaw 80
London 76
Changsha 75
Orem 75
Zhengzhou 73
Abuja 72
Ningbo 68
Haikou 67
Columbus 65
Rome 61
Denver 59
Nanchang 58
Taizhou 58
Guangzhou 55
Hangzhou 54
Redwood City 54
Brooklyn 53
Montreal 52
Falkenstein 50
Seattle 50
Jiaxing 49
San Francisco 48
Chicago 47
Toronto 46
Brussels 45
Phoenix 45
Turku 45
Taiyuan 44
Da Nang 43
Atlanta 39
Johannesburg 39
Hyderabad 38
Washington 37
Boardman 36
Boston 36
Cotonou 36
Poplar 36
Manchester 35
Norwalk 35
Chennai 34
Frankfurt am Main 34
Mexico City 34
Stockholm 33
Vienna 33
Rio de Janeiro 32
Fuzhou 30
Brasília 29
Naples 29
Tashkent 29
Amsterdam 27
Düsseldorf 27
Fairfield 27
Haiphong 27
Jakarta 26
Lanzhou 26
Dong Ket 25
Falls Church 23
Dearborn 22
Paris 22
Torino 22
Totale 23.994
Nome #
Efficacia dei bisfosfonati nella terapia della spondilite anchilosante: confronto con infliximab 708
Teriparatide and denosumab combination therapy and skeletal metabolism 348
Artrite Reumatoide e Metabolismo Minerale 271
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 271
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 265
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 255
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 254
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 245
Anti-CCP antibodies and bone 242
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 229
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 227
Bone metabolism in patients with anorexia nervosa and amenorrhoea 226
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 222
[Risk factors for hip fracture in elderly persons]. 220
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 215
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 214
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 214
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 210
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 210
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 209
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 208
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 207
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 207
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 206
[Pathophysiology of osteoarthritis: perspectives] 205
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 205
Bone involvement and osteoporosis in mastocytosis. 203
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 203
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 201
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 201
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 198
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 195
Prevalence and incidence of rheumatoid arthritis in Italy. 191
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 191
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 191
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 190
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 187
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 187
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 187
Could γ\δ T-cells explain zoledronic acid adverse events? 186
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 186
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 184
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 184
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 182
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 181
The obesity paradox and osteoporosis 179
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 179
Allergy and the bone: unexpected relationships 178
Osteopetrosi 177
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 177
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease 177
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 176
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 176
Guidelines for the diagnosis, prevention and management of osteoporosis 175
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 172
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 171
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 170
Bone Disease in Mastocytosis 170
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 170
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 168
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 168
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 167
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 167
DXA bone mineral density in males: retrospective study in real life. 166
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 165
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 165
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 165
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 165
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 165
Sclerostin and DKK1 in primary hyperparathyroidism. 164
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 164
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 164
Effects of denosumab on peripheral lymphocyte subpopulations 163
Artropatie degenerative 162
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 162
Association between environmental air pollution and rheumatoid arthritis flares 162
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 161
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 161
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 161
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 161
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 159
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 158
Prevalence of osteoporosis in patients affected by mastocytosis 157
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 157
Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer 157
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 156
Safety issues and adverse reactions with osteoporosis management 156
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 155
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 154
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 153
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study 152
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 152
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 151
Invecchiamento dell'apparato scheletrico 151
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 151
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 150
Drug-induced osteonecrosis of the jaw: the state of the art 150
Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis 150
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros 149
Relationship Between Increased Fecal Calprotectin Levels and Interstitial Lung Disease in Systemic Sclerosis 149
Totale 19.081
Categoria #
all - tutte 134.740
article - articoli 129.175
book - libri 0
conference - conferenze 667
curatela - curatele 0
other - altro 1.438
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.460
Totale 269.480


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 0 0 0 0 0 0 101
2021/20221.908 127 520 29 110 88 55 59 107 145 48 143 477
2022/20234.026 282 380 382 709 332 966 51 224 461 59 129 51
2023/20242.170 111 163 193 264 238 344 103 171 28 92 318 145
2024/20255.346 286 344 259 800 248 166 220 210 789 419 529 1.076
2025/202617.988 1.202 888 1.302 3.039 4.525 1.189 1.646 977 1.267 898 380 675
Totale 40.240